Patient Characteristics and Treatment Patterns among Medicare Beneficiaries Initiating PCSK9 Inhibitor Therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Patient Characteristics and Treatment Patterns among Medicare Beneficiaries Initiating PCSK9 Inhibitor Therapy
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-27
DOI
10.1007/s10557-020-07028-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Alirocumab
- (2019) Dhruv S. Kazi et al. ANNALS OF INTERNAL MEDICINE
- Potentially inappropriate medication use and associated healthcare utilization and Costs among older adults with colorectal, breast, and prostate cancers
- (2019) Xue Feng et al. Journal of Geriatric Oncology
- Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit
- (2019) Jennifer G. Robinson et al. Journal of Clinical Lipidology
- Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease
- (2019) Gregg C. Fonarow et al. JAMA Cardiology
- PCSK9 Inhibitors Prior Authorization
- (2019) Khurram Nasir et al.
- Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes
- (2019) Kelly D. Myers et al.
- Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia
- (2018) Dean G. Karalis et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Money-Back Guarantees on the Cost-Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors
- (2018) Dhruv S. Kazi et al. ANNALS OF INTERNAL MEDICINE
- Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis
- (2018) Carolyn T. Thorpe et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data
- (2017) Philip D Harvey et al. EUROPEAN HEART JOURNAL
- Health Spending By State 1991–2014: Measuring Per Capita Spending By Payers And Programs
- (2017) David Lassman et al. HEALTH AFFAIRS
- Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial
- (2017) Dhruv S. Kazi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice
- (2017) Kathleen A. Fairman et al. Therapeutics and Clinical Risk Management
- Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers
- (2017) Alejandro Arrieta et al. JAMA Cardiology
- Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
- (2017) Gregg C. Fonarow et al. JAMA Cardiology
- Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
- (2016) Dhruv S. Kazi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Four-Dollar Generics — Increased Accessibility, Impaired Quality Assurance
- (2010) Niteesh K. Choudhry et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now